BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Strengthens Senior Leadership Team with Appointment of Industry Veteran Richard Serbin as Head of Global Corporate DevelopmentBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessAXIM® Biotech Expands Advisory Board With Oncology Specialist and Medicinal Cannabis Leading Expert – Dr. Donald AbramsBy Nasdaq OMXMay 9, 2017, 1:02 PM UTC
BusinessCURE Pharmaceutical Adds Industry Veteran, Anti-Aging Specialist and Medicinal Cannabis Supporter, Alan Einstein, to Its Board of DirectorsBy Nasdaq OMXMay 3, 2017, 1:01 PM UTC
BusinessAXIM Biotech Receives Schedule 1 Permit to Move Forward With Development of MedChew Rx Pharmaceutical Chewing GumBy Nasdaq OMXMay 2, 2017, 1:00 PM UTC
